#1
|
||||
|
||||
Âîïðîñû êîëëåãàì
Îé, ñîððè, äóáëü.
|
#2
|
|||
|
|||
Ïðîñòèòå ÷òî âòîðãàþñü ñî ñâîèì âîïðîñîì, ìîé àíãëèéñêèé íå ïîçâîëÿåò óëîâèòü- ýòî èðîíèÿ èëè ñåðüåçíî?
Doctor, You Should Now Measure Abdominal Height Âçÿòî îòñþäà [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà. Òåðàïåâò, ïóëüìîíîëîã. |
#3
|
||||
|
||||
Abdominal Height:
1.malapropism - ïðèíÿòîå èñïîëüçîâàíèå îäíîãî ñëîâà äëÿ äðóãîãî. Íàçâàíèå âîçíèêëî îò ãîñïîæè Malaprop, õàðàêòåðà â èãðå Sheridan’s Êîíêóðåíòû (1775), êîòîðàÿ ëþáèëà èñïîëüçîâàíèå malapropos (òî åñòü íåñîîòâåòñòâóþùèå óòâåðæäåíèÿ).(Îêñôîðäñêèé ñëîâàðü). Òî åñòü ýòî äåéñòâèòåëüíî þìîð. 2. Ðàçìåð (âåëè÷èíà) æèâîòà. |
#4
|
||||
|
||||
 íàçâàíèè - òîíêèé àíãëèéñêèé þìîð (äîêòîð, èçìåðüòå ìíå æèâîò!). Ñòàòüÿ -ñåðúåçíàÿ.
Abdominal height predicts cardiovascular disease risk because it is an excellent measure of visceral adiposity or intra-abdominal fat, which is associated with insulin resistance. |
#5
|
|||
|
|||
èòàê, êîëëåãè, åòà çàìå÷àòåëüíàÿ òåìà ðàçáèòà íà íåñêîëüêî âåòîê
1. ÒËÒ ïðè âåðîÿòíîé ñïîíòàííîé ðåïåðôóçèè 2. êðèòåðèè ýôôåêòèâíîñòè ÒËÒ 3. íàãðóçî÷íàÿ äîçû äåçàãðåãàíòîâ ïðè ÎÈÌ íà ôîíå ïëàíîâîãî ïðèåìà äåçàãðåãàíòîâ 4. ýëåâàöèÿ ST 0,5 ìì. STEMI or NOSTEMI 5. íå îñëîæíåííàÿ ×Ê è àíòèêîàãóëÿíòû 6. Ïóíêöèÿ áåäðåííîé àðòåðèè: íóæíû ëè äàâÿùàÿ ïîâÿçêà è ïðåìåäèêàöèÿ 7. êëîïèäîãðåëü è êóðåíèå 8. îñîáåííîñòè ÝÊà ó áåðåìåííûõ 9. îïðåäåëåíèå ïîñòîêêëþçèîííîé ïðîõîäèìîñòè ñîñóäîâ 10. ðåâàñêóëÿðèçàöèÿ è æåçíåñïîñîáíûé ìèîêàðä 11. ëîæíûå àíåâðèçìû. ÷òî äåëàòü è êòî âèíîâàò. 12. òðåõíåäåëüíàÿ âíóòðèìîçãîâàÿ ãåìàòîìà è òàêòèêà âåäåíèÿ ïîñëå ×Ê 13. ïÿòü äíåé ïîñëå ÎÈÌ. âîçâðàò â ÁÈÒ 14. ÊÀà ïîñëå ÒËÒ åñëè áóäóò çàìå÷åíû îøèáêè, ïèøèòå, èñïðàâëþ. |
#6
|
||||
|
||||
Îäîáðÿëêà íå ïàøåò...
Ãåíèàëüíî! |
#7
|
|||
|
|||
Óâàæàåìûå êîëëåãè, ñåãîäíÿ ê íàì îáðàòèëñÿ ïàöèåíò 56-òè ëåò, ó êîòîðîãî ïðè îòñóòñòâèè êàêèõ-ëèáî êëèíè÷åñêèõ ïðîÿâëåíèé , ïðè äèñïàíñåðíîì îñìîòðå âûÿâëåíî ðàñøèðåíèå âîñõîäÿùåãî îòäåëà àîðòû. Ïî äàííûì ÝÕÎ Êà ðàñøèðåíèå âîñõîäÿùåãî îòäåëà àîðòû: íà óðîâíå ôèáðîçíîãî êîëüöà - 3,3 ñì, ñèíóñîâ Âàëüñàëüâû - 5,2ñì, âîñõîäÿùèé îòäåë - 5,0ñì, äóãà àîðòû 3,3ñì. Àîðòàëüíàÿ ðåãóðãèòàöèÿ íåçíà÷èòåëüíàÿ, äðóãèõ îñîáåííîñòåé ïðè èññëåäîâàíèè íå îáíàðóæåíî.
Ïîðåêîìåíäóéòå ïîæàëóéñòà, íàèáîëåå ïîëíûå èíñòðóêöèè, îïðåäåëÿþùèå òàêòèêó âåäåíèÿ òàêîãî áîëüíîãî è ïîêàçàíèÿ äëÿ îïåðàòèâíîãî ëå÷åíèÿ, âêëþ÷àÿ ãåíåòè÷åñêèé àíàëèç. Ñïàñèáî. |
|
#8
|
||||
|
||||
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM
Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#9
|
||||
|
||||
Óâàæàåìûå êîëëåãè, êàêàÿ, ñ âàøåé òî÷êè çðåíèÿ, äîëæíà áûòü òàêòèêà â îòíîøåíèè ïàöèåíòà ïîñëå ïåðåíåñåííîãî ÈÌ, ó êîòîðîãî íà äîáóòàìèí-ñòðåññ ÝÕÎ âîçíèê óñòîé÷èâûé ïàðîêñèçì VT ñ ×ÑÑ îêîëî 200 â ìèí ñ óäîâëåòâîðèòåëüíîé ïåðåíîñèìîñòüþ? Äàííûõ çà èøåìèþ ìèîêàðäà íå ïîëó÷åíî. Ñïàñèáî.
|
#10
|
||||
|
||||
Êîðîíàðîãðàôèÿ
|
#11
|
|||
|
|||
Óâàæàåìûé Dmblok, êðàéíå ëþáîïûòíî áûëî áû ïîëó÷èòü äîïîëíèòåëüíóþ èíôîðìàöèþ î ïàöèåíòå. ñïàñèáî
|
#12
|
||||
|
||||
Óâàæàåìàÿ Nastydoc, ñ Âàøåé òî÷êè çðåíèÿ âîçíèêíîâåíèå VT ó áîëüíîãî íà ôîíå ââåäåíèÿ äîáóòàìèíà, ñëåäóåò ðàñöåíèâàòü, êàê ïîëîæèòåëüíûé òåñò? Íå ìîãëè áû Âû óòî÷íèòü Âàøó ìûñëü? Íèêàêîé äîïîëíèòåëüíîé èíôîðìàöèè Âàì äëÿ ïðèíÿòèÿ ðåøåíèÿ íå íóæíî? To Annawolk. ß ñïåöèàëüíî íå õîòåë êàñàòüñÿ êîíêðåòíîãî áîëüíîãî - áîëüøå èíòåðåñóåò îáùèé ïîäõîä. Íî âîçìîæíî Âû ïðàâû. Áîëüíîé 48 ëåò. Òðè ìåñÿöà ïîñëå íåîñëîæíåíîãî ïåðåäíåãî ÈÌ. Ô îêîëî 40%. Ó ïàöèåíòà îêêëþçèÿ êðóïíîé âòîðîé äèàãîíàëüíîé âåòâè. Äðóãèõ çíà÷èìûõ ïîðàæåíèé íåò |
#13
|
|||
|
|||
Íàäî ïîñòàâèòü ICD
ICD therapy is indicated in patients with structural heart disease and spontaneous sustained VT, whether hemodynamically stable or unstable. (Level of Evidence: B) (16,319–324) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities |
#14
|
||||
|
||||
Öèòàòà:
|
#15
|
||||
|
||||
Öèòàòà:
Åùå õîòåëîñü áû óçíàòü áûëà ëè òàõèêàðäèÿ ïîëèìîðôîíîé èëè ìîíîìîðôíîé? |